Bristol-Myers Squibb Co
Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients […]
Read More
Forget Trump’s tariffs — here’s what is separating pharma’s winners and losers
The pharmaceutical industry has been making headlines recently, after the administration of U.S. President Donald Trump slapped 100% tariffs on branded and patented drugs But investors say drugmakers’ carve-out agreements on pricing is what will rattle the sector — and create a range of winners and losers as a result. Global pharmaceutical companies who have broken […]
Read More
Trump’s drug price ultimatum sets pharma firms scrambling
Key Points A fresh ultimatum demanding “binding commitments” to lower U.S. drug prices sent pharma firms scrambling Friday. President Trump sent letters to 17 major firms outlining the steps they must take to cut costs. Healthcare stocks tumbled Friday, following broader market losses as investors digested Trump’s amended tariffs. Pharmaceutical firms are scrambling to respond […]
Read More
Stocks making the biggest moves midday: Generac, Shake Shack, Microsoft, Meta & more
Check out the companies making the biggest moves midday: Generac — The generator company gained 8% after Bank of America raised its price target on the stock, highlighting the company’s entry into data centers . Baxter International — Shares fell around 20% after the health-care company reported weaker-than-expected results for the second quarter. Baxter reported […]
Read More
Stocks making the biggest premarket moves: CVS, Comcast, Meta, Norwegian Cruise and more
Check out the companies making the biggest moves in premarket trading: CVS Health — The stock popped 7% after the drugstore chain reported an earnings and revenue beat for its second quarter. The company also boosted its adjusted profit outlook, now expecting a range of $6.30 to $6.40 per share for fiscal 2025, up from […]
Read More
Pandemic darlings Moderna, BioNTech are now on two different paths
A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies are on different paths. Both Moderna and BioNTech helped pioneer mRNA, or […]
Read More
S&P 500 futures rise after Meta and Microsoft post quarterly beats: Live updates
A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., July 30, 2025. Jeenah Moon | Reuters S&P 500 futures and Nasdaq 100 futures rose on Wednesday evening following solid earnings reports from tech giants Microsoft and Meta Platforms. S&P 500 futures jumped 0.7%, and Nasdaq 100 […]
Read More
Trump’s pharmaceutical tariffs could affect some drugmakers more than others
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]
Read More
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
Bristol Myers Squibb and Pfizer on Thursday said they will start selling their blockbuster blood thinner, Eliquis, directly to patients at a more than 40% discount. The move comes as the Trump administration ramps up pressure on the pharmaceutical industry to cut drug prices, and threatens to impose sweeping tariffs on pharmaceuticals imported into the […]
Read More
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
U.S. President Donald Trump presents a sweeping spending and tax legislation, known as the “One Big Beautiful Bill Act,” after he signed it, at the White House in Washington, D.C., U.S., July 4, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care […]
Read More